Siren, L.L.C. Wave Life Sciences Ltd. Transaction History
Siren, L.L.C.
- $1.93 Trillion
- Q2 2025
A detailed history of Siren, L.L.C. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Siren, L.L.C. holds 3,696,322 shares of WVE stock, worth $25.5 Million. This represents 1.24% of its overall portfolio holdings.
Number of Shares
3,696,322
Previous 3,696,322
-0.0%
Holding current value
$25.5 Million
Previous $29.9 Billion
19.55%
% of portfolio
1.24%
Previous 1.68%
Shares
3 transactions
Others Institutions Holding WVE
# of Institutions
188Shares Held
133MCall Options Held
495KPut Options Held
36.2K-
Ra Capital Management, L.P. Boston, MA18.2MShares$126 Million2.59% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA15MShares$104 Million0.17% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$57.1 Million0.92% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$46.6 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.53MShares$45.1 Million0.41% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $600M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...